The MicroSafe Group manages a group of products manufactured by a United States FDA registered and regulated company, Sonoma Pharmaceuticals. These innovative products are based upon the United States FDA approved Microcyn® Technology platform. The Microcyn® Technology currently has several existing global governmental approvals including multiple United States F.D.A. approvals, multiple European Union C.E. Mark approvals, and multiple United States E.P.A. approvals, in addition to the noted approvals by the Governments of Canada, Mexico, and Australia.
The MicroSafe Group has operations in several countries with its head office in Dubai, United Arab Emirates. With several regional offices in the Middle East as well as Australia we are able to provide innovative solutions to a wide range of industries and healthcare providers. The MicroSafe group promotes only those products it believes will truly revolutionize healthcare – products that will enrich the lives of patients and healthcare professionals all over the world. Contact us today for more details and distribution opportunities.